FDA Import Refusal SCS-4727643-3/11/4 — Boehringer Ingelheim Canada
The FDA refused shipment SCS-4727643-3/11/4 from Boehringer Ingelheim Canada (Canada) on Apr 14, 2021. The refused product falls under Drugs and Biologics — PRAMIPEXOLE (ANTI-PARKINSONIAN). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Apr 14, 2021
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 62JCY15 PRAMIPEXOLE (ANTI-PARKINSONIAN)
- Charges
- 75